PCOS Rebranded as PMOS: New Name Reflects Full Metabolic, Hormonal Scope
Polycystic Ovary Syndrome (PCOS) is officially being rebranded as Polyendocrine Metabolic Ovarian Syndrome (PMOS). The change, which follows a multi-year international consensus process involving 56 academic, clinical, and patient organizations, aims to better reflect the complex metabolic and hormonal nature of the condition rather than focusing solely on ovarian morphology. Moving Beyond the Ovarian-Centric Diagnostic … Read more